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Background: Recent data suggests that atrial fibrillation (AF) is associated with worse
outcomes after PCI for STEMI. We investigated the incidence and impact of baseline and
new onset AF in pts undergoing primary PCI from the large, prospective, randomized
HORIZONS-AMI trial.
Methods: HORIZONS-AMI was a large-scale, multicenter, international, randomized
trial comparing different antithrombotic regimens and stents during primary PCI in
STEMI. The primary endpoint was net adverse cardiac events (NACE; the composite of
death, reinfarction, ischemia-driven TVR, stroke, or non-CABG-related major bleeding.
Pts with and without AF at baseline and with and without new onset AF post-PCI were
compared at 3 years.
Results: Baseline AF was present in 69/3,599 patients (1.9%), and AF developed after
PCI in an additional 172/3,358 patients (5.1%). Three-year NACE rates were not
significantly different between pts who did and did not have AF at baseline (34.2% vs.
26.4%, p0.12). Nor were the 3-year rates of mortality different in pts with and without
baseline AF (10.4% vs 6.7%, p0.22). In contrast, compared to pts who remained in sinus
rhythm, pts with new onset AF after PCI had higher 3-year rates of NACE (45.7% vs.
25.4%), mortality (14.9% vs. 6.3%), reinfarction (14.3% vs. 6.9%), stroke (7.4% vs.
1.6%) and major bleeding (21.0% vs. 8.0%) (all p0.0001). By multivariable analysis,
new onset AF was one of the strongest independent predictors of NACE (HR [95%CI]
1.80 [1.37, 2.37], p0.0001) and death (1.88 [1.23, 2.88], p0.003) at 3 years.
Conclusions: In the large, multicenter HORIZONS-AMI trial, the presence of AF at
baseline was not associated with inferior outcomes in pts with STEMI undergoing
primary PCI. However, the development of AF post-PCI was associated with markedly
higher rates of adverse events and mortality. New approaches to prevent or treat post-PCI
AF may further improve outcomes after primary PCI.
TCT-63
Remote Ischemic Perconditioning Improves Long-Term Clinical Outcome in
Patients Undergoing Primary Percutaneous Coronary Intervention for ST-
Elevation Myocardial Infarction
Astrid D Sloth1, Michael R Schmidt1, Kim Munk1, Rajesh K Kharbanda2,
Andrew N Redington3, Lars Pedersen4, Henrik T Sørensen4, Hans Erik Bøtker1
1Aarhus University Hospital, Skejby, Department of Cardiology, Denmark, 2Oxford
University Hospitals, John Radcliffe Hospital, Oxford, United Kingdom, 3Hospital
for Sick Children, Division of Cardiology, Toronto, Canada, 4Aarhus University
Hospital, Department of Clinical Epidemiology, Denmark
Background: We have previously demonstrated that remote ischemic perconditioning
(rIPerC) before primary percutaneous coronary intervention (pPCI) in patients with
ST-elevation myocardial infarction (STEMI) improves myocardial salvage. The aim of
the present study was to investigate 5-year clinical outcome.
Methods: From February 2007-November 2008, 251 patients with a first acute
ST-elevation myocardial infarction met inclusion criteria and were randomized to receive
primary percutaneous coronary intervention with (n126) or without (n125) remote
ischemic perconditioning (intermittent arm ischemia through four cycles of 5-min
inflation and 5-min deflation of a blood-pressure cuff). Patient follow-up extended from
inclusion date until death or January 2012 (median follow-up duration 3.9 years (IQR:
3.3-4.2 years)). The study endpoint was MACE (death, rehospitalisation for heart failure,
myocardial infarction, and stroke), based on data collected from Danish nationwide
registries and medical records.
Results: MACE was significantly reduced in the intervention group compared with the
control group, with a cumulative incidence of 13.0% (95% confidence interval (CI):
7.5%-20.1%) versus 24.3% (95% CI: 17.2%-32.2%) and a crude HR of 0.46 (95% CI:
0.25-0.86, p0.02). The cumulative incidence of all-cause mortality was 4.8% (95% CI:
1.7%-10.6%) in the intervention group versus 12.2% (95% CI: 7.1%-18.6%) in the
control group and a crude HR of 0.32 (95% CI: 0.12-0.88, p0.03).
Conclusions: Remote ischemic perconditioning before pPCI improves long-term clinical
outcome in patients with STEMI.
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Background: Among patients with a pre-hospital diagnosis of STEMI, emergency
medical service (EMS) transport from the field directly to the cath lab, thereby bypassing
the emergency department (ED), can potentially shorten time to reperfusion.
Methods: We studied 1,687 patients with a pre-hospital diagnosis of STEMI from the
Reperfusion in Acute MI in Carolina Emergency Rooms (RACE) project presenting via
EMS to 21 North Carolina hospitals for primary PCI between 07/2008 and 12/2009.
Reperfusion times were compared between patients evaluated in the ED (ED first) and
those transported from the field directly to the cath lab (ED bypass).
Results: Evaluation in the ED occurred in 1,401 (83.0%) patients, while the ED was
bypassed in 286 (17.0%) patients. ED bypass occurred more frequently during working
hours (Mon to Fri 0701-1800h) compared with off-hours (28.2% vs. 7.6%). Median
proportion of ED bypass at the hospital level was 12.2% (IQR 1.6%, 28%). Patients
evaluated in the ED were at higher risk with greater frequency of cardiogenic shock, and
cardiac arrest and/or need for intubation prior to PCI. Among patients evaluated in the ED,
median time from ED arrival to cath lab arrival was 30 (IQR 20, 41) mins. First medical
contact to device (FMC2D) time was shorter, and achieved in 90 mins more frequently
in ED bypass patients (Table). In-hospital mortality was lower in the ED bypass group.
Excluding high risk patients, FMC2D time remained shorter and achieved in  90 mins
more frequently in the ED bypass group. In-hospital mortality was not different between
the two groups.
Demographics, Presentation Characteristics, Treatment Times and Clinical
Outcomes of ED First and ED Bypass Patients
Variable, %
ED First
(n1401)
ED Bypass
(n286) p value
Demographics
Age, years 59 (51, 69) 60 (51, 69) 0.54
Females 29.1% 22.0% 0.02
Presentation Characteristics
Cardiogenic shock 11.0% 7.7% 0.11
Cardiac arrest/intubation
before PCI
7.4% 1.5% 0.001
Time Intervals
First medical contact to
hospital arrival, mins
32 (25, 43) 42 (30, 60) 0.001
Hospital arrival to device,
mins
55 (43, 69) 28 (20, 38) 0.001
First medical contact to
device, mins
90 (76, 109) 75 (59, 93) 0.001
First medical contact to
device  90 mins
50.1% 74.1% 0.001
Clinical Outcome
In-hospital mortality 4.6% 1.8% 0.02
Time intervals excluding
patients with cardiac
arrest/intubation
First medical contact to
device, mins
89 (75, 108) 76 (59, 92) 0.001
First medcal contact to
device  90 mins
51.7% 74.5% 0.001
Clinical Outcome excluding
patients with cardiac
arrest/intubation
In-hospital mortality 3.4% 1.8% 0.19
Conclusions: The ED is infrequently bypassed in North Carolina hospitals in patients
with pre-hospital diagnosis of STEMI. Bypassing the ED is associated with shorter
FMC2D time by approximately 15 minutes. Further exploration of patient, EMS, ED and
cath lab factors is required to develop ED bypass protocols for appropriate patients.
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